Free. Unsubscribe any time.
Monopar Therapeutics (MNPR)
Monopar Therapeutics filed 5 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 3 reporting owners, covering 19 transactions and 14,465 shares. None carries the SEC's AFF10B5ONE flag; all 5 name a plan in a footnote. No results print is on file in this window, so no interval is measured.
What stands out
- The most recent filing on file, dated 2026-08-28, came on the same day as the one before it (2026-08-28) and reports 10 transactions against 7 in the filing before it.
- The sales it reports total 4,090 shares, 948 more than the 3,142 in the filing before it.
- Its 5 filings on file run from 2026-08-27 to 2026-08-28, and state no plan adoption date.
Trades in Monopar Therapeutics 19
- Anderson Raymond — 2026-08-25 · S · 694 shares
- Anderson Raymond — 2026-08-25 · S · 646 shares
- Anderson Raymond — 2026-08-25 · S · 1,802 shares
- Anderson Raymond — 2026-08-25 · S · 694 shares
- Anderson Raymond — 2026-08-25 · S · 646 shares
- Anderson Raymond — 2026-08-25 · S · 1,802 shares
- RIOUX PATRICE — 2026-08-26 · S · 1 shares
- Tsuchimoto Kim R — 2026-08-26 · S · 485 shares
- Tsuchimoto Kim R — 2026-08-26 · S · 615 shares
- Tsuchimoto Kim R — 2026-08-26 · S · 700 shares
- Tsuchimoto Kim R — 2026-08-26 · S · 1,098 shares
- Tsuchimoto Kim R — 2026-08-26 · S · 602 shares
Adoption dates in Monopar Therapeutics 0
Results prints in Monopar Therapeutics 0
Trades before a print in Monopar Therapeutics 0
Interval to Monopar Therapeutics’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 0within 10 days
- —shortest, days
- 19no later print
Sources: SEC EDGAR full-text search and the SEC submissions API.